NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Comparison of blood RNA extraction methods used for gene expression profiling in amyotrophic lateral sclerosis.

Author(s): Bayatti N, Cooper-Knock J, Bury JJ, Wyles M, Heath PR, Kirby J, Shaw PJ

Publication: PLoS One, 2014, Vol. 9, Page e87508

PubMed ID: 24475299 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to compare gene expression profiling between specimens in the PAXgene (PAX), TEMPUS (TEM), and LEUKOLOCK (LL) blood collection and RNA extraction systems, and to determine the utility of globin depletion with GlobinClear (GC).

Conclusion of Paper

The TEM system (combined with globin depletion) and the LL system for blood collection and RNA extraction were generally superior to the PAX system (combined with globin depletion and necessary DNase treatment), giving higher RNA yields, higher RNA integrity number (RIN) values, more consistent array performance, and similar real time qRT-PCR validation of array results.

Studies

  1. Study Purpose

    The purpose of this study was to compare gene expression profiling between specimens in the PAX, TEM, and LL blood collection and RNA extraction systems, and to determine the utility of globin depletion with GlobinClear. Specimens were obtained from 8 sporadic amyotrophic lateral sclerosis (ALS) patients and 7 healthy volunteers. PAX and TEM systems use their own collection tubes, but specimens intended for LL processing were collected into K2EDTA tubes, passed through LL filter, and RNAlater was added. All specimens were frozen at -20 degrees C until analysis.

    Summary of Findings:

    The highest quantity of RNA was extracted using the TEM system, followed by the PAX system, and lastly, the LL system. TEM and LL-extracted RNA showed high quality (RIN >7.0) without DNase treatment. However, PAX-extracted RNA needed to undergo DNase treatment before high quality RNA was obtained. This DNase treatment also decreased the yield of RNA from PAX-extracted specimens. Further, globin mRNA depletion by GC lowered the RIN values for PAX-extracted RNA (PAX RIN=7.9, PAX GC RIN=7.2) but not for TEM-extracted RNA (both RIN=7.9). In general, PAX RNA array hybridizations showed the most variability. GC treatment increased the microarray percent present calls for PAX and TEM-extracted RNA from 39% and 43%, respectively, to 50% for each, the same as LL-extracted RNA. In addition, globin clearance unmasked transcripts that were otherwise not detected (6022 probe sets). The PAX GC RNA and TEM GC RNA had more differentially-regulated probe sets between ALS patients and healthy controls in common than either did with LL RNA. For both TEM GC specimens and LL specimens, 4 out of 6 genes chosen for validation of differential expression between ALS patients and healthy controls were indeed validated. The authors report that PAX GC specimens were not used for validation due to the longer preparation time required.

    Biospecimens
    Preservative Types
    • Frozen
    • Other Preservative
    • PAXgene
    Diagnoses:
    • Normal
    • Other diagnoses
    Platform:
    AnalyteTechnology Platform
    RNA DNA microarray
    RNA Real-time qRT-PCR
    RNA Automated electrophoresis/Bioanalyzer
    RNA Spectrophotometry
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Type of collection container/solution PAXgene collection tube
    TEMPUS collection tube
    K2EDTA Vacutainer
    Preaquisition Diagnosis/ patient condition Amyotrophic lateral sclerosis
    Healthy
    Analyte Extraction and Purification Analyte isolation method PAX
    TEM
    LL
    Analyte Extraction and Purification Analyte purification Globin depletion
    No globin depletion
    Analyte Extraction and Purification Nucleic acid digestion DNase treatment
    No DNase treatment

You Recently Viewed  

News and Announcements

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • Most Downloaded SOPs in January and February of 2024

  • More...